What We Do:
NIDA's AIDS Research Program (ARP) supports the development, planning, and coordination of high priority research at the intersection HIV/AIDS and substance use disorders within NIDA, NIH Institutes and other DHHS agencies.
NIDA HIV Research Priority Areas
To support research at the intersection of substance use, HIV, and related comorbidities and generate evidence-based strategies to improve individual and public health:
- Prevent new infections and transmission of HIV among people who use drugs and their sexual and/or injection partners.
- Increase understanding of etiology, pathogenesis, spread, and persistence of HIV/AIDS among people who use drugs.
- Address comorbidities and improve health outcomes among people living with HIV who use drugs.
- Accelerate scientific discoveries in HIV/AIDS and substance use research.
- NIH HIV/AIDS Research Priorities Webinar and FAQs (4/21/16)
- NIDA AIDS Research Program Update: High Priority Research Areas - Council Presentation from 9/5/19, (PDF, 2.82 MB)
- Fiscal Year 2018 Funding Priorities (PDF 342KB)
- NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding - NOT-OD-15-137
- Statement on NIH Efforts to Focus Research to End the AIDS Pandemic , NIH Director, Dr. Collins (8/12/15)
- Research Training & Career Development
- Minority Training Programs - Office of Diversity and Health Disparities (ODHD)